Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...

The majority of materials we rely on in our built environment come from chemicals derived from petroleum (petrochemicals), ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

For patients with type 2 diabetes (T2D), duodenal recellularization via electroporation therapy (ReCET) is feasible and safe and can prevent the need for insulin therapy when combined with semaglutide ...

The Affera mapping and ablation system is the first on the market that can deliver both pulsed-field and radiofrequency ...

1. AngioDynamics announces American Medical Association’s CPT Editorial Panel grants category I CPT for irreversible electroporation (IRE) in prostate and liver. News release. AngioDynamics, Inc.

This innovative approach, which combines a novel procedure known as ReCET (Re-Cellularization via Electroporation Therapy) with semaglutide, resulted in the elimination of insulin therapy for 86% of ...

Vienna — Participants with type 2 diabetes who were able to stop insulin for up to 12 months after receiving the novel recellularization via electroporation therapy (ReCET) procedure in ...

MONDAY, Oct. 14, 2024 (HealthDay News) -- Results from a very small study suggest that a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could help erase the need ...

1 This innovative approach, which combines a novel procedure known as ReCET (Re-Cellularization via Electroporation Therapy) with semaglutide, resulted in the elimination of insulin therapy for 86 ...

More information: Busch, C.B.E, et al. Durable effects of duodenal ablation using electroporation combined with semaglutide to eliminate insulin therapy in patients with type-2 diabetes; the 24 ...